77 related articles for article (PubMed ID: 20617549)
21. A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer.
Li F; Ren GS; Li HY; Wang XY; Chen L; Li J
Clin Oncol (R Coll Radiol); 2009 May; 21(4):302-5. PubMed ID: 19138835
[TBL] [Abstract][Full Text] [Related]
22. Re: Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.
Ambrosone CB; Shields PG; Freudenheim JL; Hong CC
J Natl Cancer Inst; 2007 Mar; 99(6):487; author reply 488-9. PubMed ID: 17374839
[No Abstract] [Full Text] [Related]
23. HLA-G polymorphism and breast cancer.
Rolfsen GB; Castelli EC; Donadi EA; Duarte RA; Soares CP
Int J Immunogenet; 2014 Apr; 41(2):143-8. PubMed ID: 24164707
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor-α 308 G/A polymorphism in breast cancer risk.
Ding Z; Jiang F; Ding X; Chen S; Lv G
Breast Cancer Res Treat; 2011 Jul; 128(2):593-4. PubMed ID: 21350819
[No Abstract] [Full Text] [Related]
25. DNA microarray-based analysis of single nucleotide polymorphisms may be useful for assessing the risks and benefits of hormone therapy.
Tempfer CB; Riener EK; Hefler LA; Huber JC; Muendlein A
Fertil Steril; 2004 Jul; 82(1):132-7. PubMed ID: 15237001
[TBL] [Abstract][Full Text] [Related]
26. Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk.
Yang R; Dick M; Marme F; Schneeweiss A; Langheinz A; Hemminki K; Sutter C; Bugert P; Wappenschmidt B; Varon R; Schott S; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Müller H; Arndt V; Brenner H; Sohn C; Burwinkel B
Breast Cancer Res Treat; 2011 Jun; 127(2):549-54. PubMed ID: 21046227
[TBL] [Abstract][Full Text] [Related]
27. A case-control study of the HER2 Ile655Val polymorphism and risk of breast cancer in Taiwan.
Lee SC; Hou MF; Hsieh PC; Wu SH; Hou LA; Ma H; Tsai SM; Tsai LY
Clin Biochem; 2008 Feb; 41(3):121-5. PubMed ID: 18062925
[TBL] [Abstract][Full Text] [Related]
28. [Breast cancer: reasons for the continuous increase in incidence].
Pigné A
Presse Med; 2007 Feb; 36(2 Pt 2):312-4. PubMed ID: 17258680
[No Abstract] [Full Text] [Related]
29. [Polymorphism Lys751Gln of XPD gene and breast cancer risk in women].
Romanowicz-Makowska H; Smolarz B
Pol Merkur Lekarski; 2007 Aug; 23(134):107-9. PubMed ID: 18044339
[TBL] [Abstract][Full Text] [Related]
30. A functional -77T>C polymorphism in XRCC1 is associated with risk of breast cancer.
Liu L; Yuan P; Liu L; Wu C; Zhang X; Guo H; Zhong R; Xu Y; Wu J; Duan S; Rui R; Wu T; Nie S; Miao X; Lin D
Breast Cancer Res Treat; 2011 Jan; 125(2):479-87. PubMed ID: 20549339
[TBL] [Abstract][Full Text] [Related]
31. Genetic Variations in ABCG2 Gene Predict Breast Carcinoma Susceptibility and Clinical Outcomes after Treatment with Anthracycline-Based Chemotherapy.
Wu H; Liu Y; Kang H; Xiao Q; Yao W; Zhao H; Wang E; Wei M
Biomed Res Int; 2015; 2015():279109. PubMed ID: 26634205
[TBL] [Abstract][Full Text] [Related]
32. Polymorphic variations in exon 10 of the luteinizing hormone receptor: functional consequences and associations with breast cancer.
Piersma D; Verhoef-Post M; Look MP; Uitterlinden AG; Pols HA; Berns EM; Themmen AP
Mol Cell Endocrinol; 2007 Sep; 276(1-2):63-70. PubMed ID: 17709176
[TBL] [Abstract][Full Text] [Related]
33. Differential roles of Angiotensinogen and Angiotensin Receptor type 1 polymorphisms in breast cancer risk.
González-Zuloeta Ladd AM; Arias Vásquez A; Siemes C; Yazdanpanah M; Coebergh JW; Hofman A; Stricker BH; van Duijn CM
Breast Cancer Res Treat; 2007 Mar; 101(3):299-304. PubMed ID: 16823505
[TBL] [Abstract][Full Text] [Related]
34. Association of CCND1 Gene c.870G>A Polymorphism with Breast Cancer Risk: A Case-ControlStudy and a Meta-Analysis.
Soleimani Z; Kheirkhah D; Sharif MR; Sharif A; Karimian M; Aftabi Y
Pathol Oncol Res; 2017 Jul; 23(3):621-631. PubMed ID: 28004353
[TBL] [Abstract][Full Text] [Related]
35. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
[TBL] [Abstract][Full Text] [Related]
36. A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population.
Alshatwi AA; Hasan TN; Shafi G; Alsaif MA; Al-Hazzani AA; Alsaif AA
Fundam Clin Pharmacol; 2012 Jun; 26(3):438-43. PubMed ID: 21477265
[TBL] [Abstract][Full Text] [Related]
37. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.
Sigurdson AJ; Hauptmann M; Chatterjee N; Alexander BH; Doody MM; Rutter JL; Struewing JP
BMC Cancer; 2004 Mar; 4():9. PubMed ID: 15113441
[TBL] [Abstract][Full Text] [Related]
38. Single nucleotide polymorphism (SNP) Thr241Met in the XRCC3 gene and breast cancer risk in Polish women.
Romanowicz-Makowska H; Bryś M; Forma E; Maciejczyk R; Połać I; Samulak D; Michalska M; Smolarz B
Pol J Pathol; 2012 Jun; 63(2):121-5. PubMed ID: 22864780
[TBL] [Abstract][Full Text] [Related]
39. Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies.
Mocellin S; Tropea S; Benna C; Rossi CR
BMC Med; 2018 Feb; 16(1):20. PubMed ID: 29455641
[TBL] [Abstract][Full Text] [Related]
40. [Remarks of the Zurich Discussion Panel on the gene test].
Birkhäuser M; Braendle W; Breckwoldt M; Keller PJ; Kiesel L
Gynakol Geburtshilfliche Rundsch; 2003 Jan; 43(1):43-52. PubMed ID: 12561783
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
